Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER)

Abstract Background Ultra-hypofractionated image-guided stereotactic body radiotherapy (SBRT) is increasingly used for definitive treatment of localized prostate cancer. Magnetic resonance imaging-guided radiotherapy (MRgRT) facilitates improved visualization, real-time tracking of targets and/or or...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Ariel E. Marciscano, Sydney Wolfe, Xi Kathy Zhou, Christopher E. Barbieri, Silvia C. Formenti, Jim C. Hu, Ana M. Molina, David M. Nanus, Jones T. Nauseef, Douglas S. Scherr, Cora N. Sternberg, Scott T. Tagawa, Himanshu Nagar
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Subjects:	Prostate cancer Salvage radiotherapy Stereotactic body radiotherapy (SBRT) MR-Linac MRI-guided radiotherapy (MRgRT) Genitourinary
Online Access:	https://doi.org/10.1186/s12885-023-11278-3